
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter C - Drugs: General
#### PART 201 - LABELING
##### Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin
###### ยง 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in ยง 201.56(b)(1).
####### 1,Drug not absorbed systemically.,Name of drug,name of drug

()If data demonstrate that the drug is not systemically absorbed by the mother, the Risk Summary must contain only the following statement: "() is not absorbed systemically by the mother following (route of administration), and breastfeeding is not expected to result in exposure of the child to ()."
